Forward Pharma A Price History
FWPDelisted Stock | USD 2.56 0.00 0.00% |
If you're considering investing in Forward Stock, it is important to understand the factors that can impact its price. As of today, the current price of Forward Pharma stands at 2.56, as last reported on the 24th of April, with the highest price reaching 2.56 and the lowest price hitting 2.56 during the day. We have found twenty-five technical indicators for Forward Pharma A, which you can use to evaluate the volatility of the firm. Please confirm Forward Pharma's Downside Deviation of 9.18, mean deviation of 3.81, and Coefficient Of Variation of 5208.24 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
Forward Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Forward |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
FWP |
Based on monthly moving average Forward Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Forward Pharma by adding Forward Pharma to a well-diversified portfolio.
Forward Pharma Stock Price History Chart
There are several ways to analyze Forward Stock price data. The simplest method is using a basic Forward candlestick price chart, which shows Forward Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Forward Stock Price History Data
The price series of Forward Pharma for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 3.19 with a coefficient of variation of 19.02. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.57. The median price for the last 90 days is 2.63. The company completed 1:7 stock split on 6th of December 2019. Forward Pharma A completed dividends distribution on 2017-09-12.Open | High | Low | Close | Volume | ||
04/24/2024 | 2.56 | 2.56 | 2.56 | 2.56 | ||
02/28/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/27/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/24/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1,000.00 | |
02/23/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/22/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/21/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1,482 | |
02/17/2023 | 2.60 | 2.60 | 2.60 | 2.60 | 412.00 | |
02/16/2023 | 2.59 | 2.59 | 2.59 | 2.59 | 1.00 | |
02/15/2023 | 2.59 | 2.59 | 2.59 | 2.59 | 610.00 | |
02/14/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/13/2023 | 2.56 | 2.56 | 2.56 | 2.56 | 1.00 | |
02/10/2023 | 2.60 | 2.60 | 2.56 | 2.56 | 300.00 | |
02/09/2023 | 2.55 | 2.55 | 2.55 | 2.55 | 1.00 | |
02/08/2023 | 2.55 | 2.55 | 2.55 | 2.55 | 100.00 | |
02/07/2023 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
02/06/2023 | 2.06 | 2.70 | 2.06 | 2.70 | 201.00 | |
02/03/2023 | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 | |
02/02/2023 | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 | |
02/01/2023 | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 | |
01/31/2023 | 2.99 | 3.00 | 2.99 | 3.00 | 930.00 | |
01/30/2023 | 2.04 | 3.00 | 2.04 | 3.00 | 631.00 | |
01/27/2023 | 3.00 | 3.00 | 3.00 | 3.00 | 15,061 | |
01/26/2023 | 3.00 | 3.00 | 3.00 | 3.00 | 1,842 | |
01/25/2023 | 2.98 | 3.14 | 2.98 | 3.14 | 906.00 | |
01/24/2023 | 2.90 | 2.90 | 2.83 | 2.84 | 1,101 | |
01/23/2023 | 2.78 | 2.78 | 2.78 | 2.78 | 1,122 | |
01/20/2023 | 2.91 | 2.91 | 2.91 | 2.91 | 1.00 | |
01/19/2023 | 2.70 | 2.94 | 2.70 | 2.91 | 8,190 | |
01/18/2023 | 2.55 | 2.55 | 2.55 | 2.55 | 225.00 | |
01/17/2023 | 2.47 | 2.47 | 2.47 | 2.47 | 424.00 | |
01/16/2023 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
01/13/2023 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
01/12/2023 | 2.56 | 2.70 | 2.56 | 2.70 | 3,149 | |
01/11/2023 | 2.61 | 2.65 | 2.61 | 2.63 | 5,311 | |
01/10/2023 | 2.48 | 2.48 | 2.48 | 2.48 | 4,544 | |
01/09/2023 | 2.26 | 2.26 | 2.23 | 2.23 | 601.00 | |
01/06/2023 | 2.18 | 2.26 | 2.18 | 2.26 | 715.00 | |
01/05/2023 | 2.21 | 2.21 | 2.16 | 2.20 | 9,204 | |
01/04/2023 | 2.21 | 2.25 | 2.21 | 2.21 | 5,321 | |
01/03/2023 | 1.95 | 1.95 | 1.80 | 1.95 | 4,348 | |
12/30/2022 | 2.15 | 2.15 | 1.89 | 1.95 | 7,019 | |
12/29/2022 | 1.95 | 2.20 | 1.88 | 2.16 | 1,725 | |
12/28/2022 | 1.43 | 1.98 | 1.43 | 1.98 | 103,085 | |
12/27/2022 | 1.94 | 2.06 | 1.94 | 1.95 | 29,554 | |
12/23/2022 | 1.95 | 2.08 | 1.81 | 1.81 | 49,600 | |
12/22/2022 | 1.83 | 1.98 | 1.83 | 1.96 | 3,500 | |
12/21/2022 | 1.81 | 2.00 | 1.79 | 1.80 | 45,000 | |
12/20/2022 | 1.75 | 1.89 | 1.70 | 1.81 | 127,100 | |
12/19/2022 | 2.35 | 2.35 | 1.50 | 1.79 | 101,500 | |
12/16/2022 | 2.64 | 2.64 | 2.60 | 2.61 | 1,000.00 | |
12/15/2022 | 2.37 | 2.66 | 2.37 | 2.66 | 700.00 | |
12/14/2022 | 2.93 | 2.93 | 2.72 | 2.72 | 1,500 | |
12/13/2022 | 2.96 | 3.00 | 2.96 | 3.00 | 400.00 | |
12/12/2022 | 2.70 | 3.00 | 2.70 | 2.97 | 3,300 | |
12/09/2022 | 2.69 | 2.69 | 2.66 | 2.66 | 400.00 | |
12/08/2022 | 2.85 | 2.85 | 2.85 | 2.85 | 1,300 | |
12/07/2022 | 2.97 | 2.97 | 2.72 | 2.92 | 2,200 | |
12/06/2022 | 2.80 | 3.19 | 2.40 | 3.19 | 3,800 | |
12/05/2022 | 2.81 | 2.81 | 2.81 | 2.81 | 166.00 | |
12/02/2022 | 2.80 | 2.90 | 2.80 | 2.81 | 800.00 |
About Forward Pharma Stock history
Forward Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Forward is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Forward Pharma A will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Forward Pharma stock prices may prove useful in developing a viable investing in Forward Pharma
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Forward Pharma Stock Technical Analysis
Forward Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
All Next | Launch Module |
Forward Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Forward Pharma's price direction in advance. Along with the technical and fundamental analysis of Forward Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Forward to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.021 | |||
Jensen Alpha | (0.06) | |||
Total Risk Alpha | (0.79) | |||
Sortino Ratio | 0.0035 | |||
Treynor Ratio | 0.0579 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Forward Stock
If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |